Abstract
This study was aimed to evaluate the prevalence and characteristics of post-acute sequelae of COVID-19 (PASC) in cystic fibrosis (CF) pediatric patients, including clinical data, persistent symptoms, change in pulmonary exacerbations and self-rated health.
Accepted Version
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have